Clinical trials: Rhinitis, Allergic, Seasonal
Cedar Pollinosis
A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy
Examine safety and immunological response for ASP4070 when vaccinated in patients with pollen allergy
- Trial name
- NCT02469688
- Testing
- ASP4070
- Where
- Japan
- Volunteers
- 66 people
- Sponsor
- Astellas Pharma Inc
Seasonal Allergy
Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen
The primary objective of this study is to demonstrate the superiority of 2L®ALERG over placebo in terms of efficacy on the symptoms of allergic rhinitis and allergic rhinoconjunctivitis in patients with seasonal allergy to grass…
- Trial name
- LLB-2016-01 (NCT02690935)
- Testing
- 2LALERG
- Where
- Belgium
- Volunteers
- 102 people
- Sponsor
- Labo'Life
Rhinitis, Allergic, Perennial and Seasonal
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
This phase IV investigational trial is being conducted to evaluate the efficacy of a 2-week treatment of fluticasone propionate nasal spray (FPNS) vs.
- Trial name
- NCT01916226
- Testing
- FPNS, Cetirizine
- Where
- 31 sites in United States
- Volunteers
- 682 people
- Sponsor
- GlaxoSmithKline
Seasonal Allergic Rhinitis
Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit
The primary objective of this study is to determine the efficacy and onsets of action of single-dose fexofenadine hydrochloride 180 mg and montelukast sodium 10 mg relative to placebo.
- Trial name
- NCT00637611
- Testing
- Fexofenadine HCl
- Where
- United States
- Volunteers
- 1,010 people
- Sponsor
- Sanofi
Seasonal Allergies
MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)
To assess the efficacy of MK0524 on seasonal allergies.
- Trial name
- NCT00533208
- Testing
- MK0524
- Volunteers
- 766 people
- Sponsor
- Merck Sharp & Dohme LLC
Allergic Rhinoconjunctivitis
Tolerability of Grazax in Patients With Hayfever in Real Life Settings
The purpose of this study is to assess the safety profile of specific immunotherapy with Grazax for three consecutive grass pollen seasons.
- Trial name
- GRAAL (NCT01433510)
- Testing
- Grazax
- Where
- France
- Volunteers
- 628 people
- Sponsor
- ALK-Abelló A/S